Crédit Mutuel Innovation

Crédit Mutuel Innovation is a Paris-based venture capital arm that backs early to growth-stage companies in life sciences, digital and deep tech. It typically invests €1–€20 million per deal and supports entrepreneurs through a global ecosystem that includes portfolio companies, international subsidiaries, and collaborations with major global corporations and leading experts. The firm focuses on durable partnerships with visionary leaders to help portfolio companies scale and achieve lasting growth.

Cyrus Contant

Investment Director

Stéphane Simoncini

Investment Director

Past deals in France

HarfangLab

Series A in 2023
HarfangLab specializes in developing advanced software aimed at enhancing the detection and neutralization of cyberattacks on corporate endpoints. Their cloud-based platform integrates with third-party cybersecurity solutions to provide comprehensive visibility across systems. The software facilitates real-time threat identification, investigation, and elimination, significantly improving the efficiency of threat management. HarfangLab's team comprises specialists with extensive experience in both defensive and offensive cyber operations, having previously worked with the French National Agency for the Security of Information Systems, the French Ministry of Defense, and leading cybersecurity firms. This expertise positions HarfangLab as a key player in delivering robust cybersecurity solutions for organizations seeking to protect their digital assets.

TISSIUM

Series D in 2023
TISSIUM is a Paris-based medical device company focused on biodegradable programmable polymer technology for tissue reconstruction and surgical wound closure, particularly in minimally invasive procedures. Its non-toxic sealants and adhesives are designed to bind strongly to tissues and provide immediate closure in the body's wet, dynamic environments, enabling rapid wound management across multiple clinical areas. The company builds on intellectual property and research associated with leading researchers Robert Langer and Jeff Karp. These core capabilities support applications in tissue repair and potential localized drug delivery.

MedinCell

Post in 2021
MedinCell S.A. is a pharmaceutical company focused on developing innovative therapeutic solutions through its proprietary BEPO technology, which facilitates long-acting injectable products utilizing biodegradable polymers and a biocompatible solvent. Based in Jacou, France, the company is engaged in ongoing research and development to optimize the efficiency and accessibility of medical treatments across various therapeutic areas. MedinCell's product pipeline includes several candidates, such as mdc-IRM, a subcutaneous injection for schizophrenia currently in Phase III trials, and mdc-CWM, an intra-articular injection aimed at treating pain and inflammation. Additionally, the company is exploring formulations like mdc-WWM for contraception and mdc-ANG for central nervous system disorders, alongside other candidates targeting pain management and organ transplant applications. Through its advancements in controlled, long-acting injectables, MedinCell aims to enhance treatment outcomes for patients.

AB Tasty

Series C in 2020
AB Tasty is a Paris-based software company that provides a cloud-based platform for experimentation, personalization, and product optimization. The platform supports marketing, product, and technical teams by collecting online usage data and turning website, mobile, and application visitors into customers, subscribers, and leads. It offers feature management, A/B, multivariate, and multipage testing, along with personalization and engagement tools to improve conversion rates, user experiences, and revenue across digital assets and channels. The solution is designed for industries such as e-commerce, retail, travel, luxury and fashion, media, and financial services. Founded in 2009, AB Tasty helps teams launch better products faster and act on customer insights to optimize performance.

MaaT Pharma

Series B in 2020
MaaT Pharma, based in Lyon, France, is a clinical-stage biotechnology company founded in 2014 that specializes in the development of microbiome-based therapies aimed at treating diseases associated with gut microbiota imbalance. The company focuses on improving survival outcomes in patients with life-threatening conditions, particularly cancers and Graft-versus-Host Disease, a serious complication following allogeneic stem cell transplantation. MaaT Pharma has demonstrated proof of concept in acute myeloid leukemia patients and is actively expanding its pipeline to enhance outcomes in immunotherapy for solid tumors. Central to its research efforts is the GutPrint® platform, which facilitates the evaluation of drug candidates, identification of novel disease targets, and discovery of biomarkers related to microbiome-associated conditions.

TISSIUM

Series B in 2019
TISSIUM is a Paris-based medical device company focused on biodegradable programmable polymer technology for tissue reconstruction and surgical wound closure, particularly in minimally invasive procedures. Its non-toxic sealants and adhesives are designed to bind strongly to tissues and provide immediate closure in the body's wet, dynamic environments, enabling rapid wound management across multiple clinical areas. The company builds on intellectual property and research associated with leading researchers Robert Langer and Jeff Karp. These core capabilities support applications in tissue repair and potential localized drug delivery.

Wizaplace

Venture Round in 2019
Founded in 2012, Wizaplace is a French software company that provides an all-in-one SaaS platform for creating and managing marketplaces. Its solution integrates essential functions for building and operating B2C, B2B, C2C, and tailor-made service marketplaces, along with e-commerce, crowdfunding, and collaborative platforms.

Diota

Series B in 2019
Diota is a company based in Massy, France, specializing in augmented reality (AR) software solutions tailored for industrial applications. Founded in 2009, the company focuses on integrating digital data with human operators to enhance the efficiency of complex industrial processes. Its flagship product, DiotaPlayer, facilitates the use of AR across various industrial sectors, including manufacturing, aerospace, automotive, and oil and gas. The software allows users to browse, interact with, check, report, and track information seamlessly within existing hardware and software environments. Diota’s solutions are compatible with multiple devices, such as tablets and head-mounted displays, making them versatile for different operational needs. Additionally, the company offers consulting, technical support, and training services to optimize the implementation of its technologies. Diota's client base includes major industry players such as Safran Group, Dassault Aviation, and Renault, positioning it as a key contributor to the digital transformation of the industrial landscape in Europe.

Menway

Venture Round in 2017
Menway is a manpower recruitment firm established in 2002 and headquartered in Metz, France. As a subsidiary of Groupe MENWAY SAS since 2008, the company specializes in offering customized solutions to address various human resources challenges. Menway provides a diverse array of skills and services designed to meet the specific needs of both businesses and employees, ensuring effective recruitment and workforce management.

Hemarina

Series C in 2017
Hemarina is a privately held biotechnology company based in Morlaix, France, focused on research and development of oxygen transport agents derived from marine invertebrates for medical and industrial applications. Building on extracellular hemoglobin research, the company develops hemoglobin‑based oxygen carriers and related products to improve tissue oxygenation, preserve organs, and support cell culture and biopharmaceutical processes. Its product portfolio includes HEMO2life, an additive for organ preservation solutions that enables oxygenation and reduces rejection risk; HEMHealing, an oxygenating dressing for hypoxic and chronic wounds; and HEMOXYCarrier, a universal oxygen carrier designed to minimize adverse vasoconstriction. The company also develops HEMOXCell/HEMUPStream platforms for cell culture and protein production, as well as M101 and other oxygenation technologies used in medical devices and drug development. Hemarina serves life sciences and pharmaceutical customers, collaborating with academic and clinical partners to advance organ preservation, wound healing, and oxygenation-based therapies.

Frénéhard & Michaux

Venture Round in 2016
Frénéhard & Michaux is a prominent French industrial group that specializes in the building envelope, focusing on fall protection solutions and safety for work at height. The company manufactures metal products tailored for roofers and provides a range of services including access and work-at-height solutions, roofing and fixing accessories, as well as fall arrest systems. They also offer engineering, training, and audit services to enhance safety and efficiency for professionals in the construction and industry sectors. Frénéhard & Michaux aims to strengthen its core business, leverage historical brands for new market opportunities, and enhance its presence throughout Europe by pooling research and development resources to innovate and expand its product offerings.

Sigma Informatique

Venture Round in 2016
Sigma Informatique is a French IT services provider offering software publishing, consulting and integration, managed services, information systems outsourcing, and cloud solutions. It serves more than 2,200 customers across France in sectors such as retail, social housing, health, insurance, and administration, delivering end-to-end support for IT projects and digital transformation.

Aries Alliance

Venture Round in 2016
Aries Alliance, founded in 2000 and based in Nantes, France, specializes in the fabrication of metal shaping machines and presses, as well as the production of aerospace parts. The company develops a range of hydraulic presses, metal forming machines, and custom stretch forming presses, alongside machine tools designed for milling, pocketing, and high-speed applications. Aries Alliance also manufactures cold formed, hot formed, and friction welded components specifically for the aerospace industry. Its clientele includes companies that design and produce parts for various aeronautical applications, including structures, engines, aircraft, helicopters, missiles, and launchers across both civil and military sectors on a global scale. The company is committed to delivering comprehensive solutions that encompass machinery, tools, simulation software, turnkey workshops, and part production for aircraft metal forming and large-scale machining.

InFlectis BioScience

Series A in 2016
InFlectis BioScience is a drug discovery company headquartered in Nantes, France, established in 2013. The company specializes in developing small molecule drugs that target the unfolded protein response, a crucial mechanism for managing misfolded proteins that can lead to neurodegenerative and age-related diseases. By leveraging its expertise in cellular defense systems, InFlectis BioScience focuses on modulating key proteins involved in misfolded protein disorders, addressing the challenges posed by endoplasmic reticulum stress. This innovative approach aims to improve cellular function and survival, ultimately enhancing patient care and addressing significant health issues related to protein misfolding.

MaaT Pharma

Series A in 2016
MaaT Pharma, based in Lyon, France, is a clinical-stage biotechnology company founded in 2014 that specializes in the development of microbiome-based therapies aimed at treating diseases associated with gut microbiota imbalance. The company focuses on improving survival outcomes in patients with life-threatening conditions, particularly cancers and Graft-versus-Host Disease, a serious complication following allogeneic stem cell transplantation. MaaT Pharma has demonstrated proof of concept in acute myeloid leukemia patients and is actively expanding its pipeline to enhance outcomes in immunotherapy for solid tumors. Central to its research efforts is the GutPrint® platform, which facilitates the evaluation of drug candidates, identification of novel disease targets, and discovery of biomarkers related to microbiome-associated conditions.

TISSIUM

Series A in 2016
TISSIUM is a Paris-based medical device company focused on biodegradable programmable polymer technology for tissue reconstruction and surgical wound closure, particularly in minimally invasive procedures. Its non-toxic sealants and adhesives are designed to bind strongly to tissues and provide immediate closure in the body's wet, dynamic environments, enabling rapid wound management across multiple clinical areas. The company builds on intellectual property and research associated with leading researchers Robert Langer and Jeff Karp. These core capabilities support applications in tissue repair and potential localized drug delivery.

Caravane

Private Equity Round in 2016
Founded in Paris in 1992, Caravane is a French company specializing in the manufacture and distribution of home furnishings. It offers a wide range of products including beds, sofas, textiles, lamps, and tableware, sold through its own stores and international retailers.

ABEO SAS

Venture Round in 2015
ABEO SAS is a France-based company that focuses on the design, manufacturing, and marketing of sports and leisure equipment. The company develops and retails a range of sporting products, including equipment for gymnastics, climbing, basketball, and combat sports. ABEO supports a diverse clientele, including specialized sports halls, clubs, leisure centers, educational institutions, local authorities, and construction professionals, assisting them in the implementation of their projects. Additionally, the company provides equipment for locker rooms and bathrooms, catering to various needs within the sports and leisure sectors across Europe.

Capelle Groupe

Venture Round in 2015
Capelle Groupe is a transportation company that specializes in providing solutions for oversize and heavy loads, utilizing flatbed and low loader trailers. Over the years, it has established itself as a leader in oversized transport in France and offers services internationally. Through its subsidiaries, Capelle Groupe delivers comprehensive transportation solutions to meet the diverse needs of its clients.

ENAG S.A.S.

Venture Round in 2014
ENAG S.A.S., based in Quimper, France, specializes in the design, development, and manufacture of industrial electrical equipment, having been established in 1946. The company offers a diverse range of products, including power alternators, discharge banks, battery chargers, DC/DC converters, frequency converters, inverters, radiators, and fans, as well as motor and propulsion systems and uninterruptible power supplies. With over 70 years of expertise, ENAG serves various sectors such as marine, defense, railway, and offshore industries, providing static and dynamic energy conversion solutions that meet specific environmental and technical constraints. The company's focus on customer needs drives the innovation and development of its products, which are designed for operation in challenging and secure environments.

Cap Ingelec

Venture Round in 2013
Founded in 1992, Cap Ingelec is a leading French engineering firm specializing in electrical engineering services. It offers preliminary studies, engineering design execution, project management, technical studies, and energy efficiency solutions for complex buildings, industrial facilities, critical infrastructures, data centers, luxury buildings, and other sectors that require high reliability.

Lucibel

Venture Round in 2013
Lucibel is a French company that specializes in designing and manufacturing advanced lighting products and solutions utilizing LED technology. Committed to sustainability and efficiency, Lucibel's offerings are not only energy-efficient but also integrate smart features that facilitate remote management. Their innovative lighting solutions enable real-time control and measurement, allowing light to interact dynamically with its environment. Additionally, Lucibel's technology supports new forms of data transmission and enhances user well-being, positioning the company at the forefront of the digital lighting era.

Lucibel

Venture Round in 2013
Lucibel is a French company that specializes in designing and manufacturing advanced lighting products and solutions utilizing LED technology. Committed to sustainability and efficiency, Lucibel's offerings are not only energy-efficient but also integrate smart features that facilitate remote management. Their innovative lighting solutions enable real-time control and measurement, allowing light to interact dynamically with its environment. Additionally, Lucibel's technology supports new forms of data transmission and enhances user well-being, positioning the company at the forefront of the digital lighting era.

Coldway SA

Venture Round in 2013
Coldway SA is a French company that specializes in the development and sale of autonomous cold groups designed for mobile applications. The company has pioneered a patented sorption technology that enables the production of cold and heat on demand, without the need for external energy sources. This innovation allows for the storage and use of industrial cold in various conditions, making it particularly beneficial for industries such as agri-food, medical, logistics, and transport. Coldway's solid-gas refrigeration units are integrated into isothermal containers, ensuring the safe transport of temperature-sensitive products while maintaining strict sanitary standards and traceability. The technology is mobile, reusable, and does not rely on consumables, providing a versatile solution for temperature control in diverse environments.

e(ye)BRAIN

Series B in 2012
e(ye)BRAIN SA is a medical company specializing in the development and manufacturing of eye trackers designed for the diagnosis of neurological and psychiatric diseases. Founded in 2008 and based in Paris, France, the company offers two primary products: EyeBrain T1 and EyeBrain T2. The EyeBrain T1 allows users to record eye movements, while the EyeBrain T2 incorporates advanced algorithms to capture both eye and head movements. These recorded movements are then analyzed using the MeyeEval software. In addition to its product offerings, e(ye)BRAIN provides advisory, paradigm development, training, and support services to its clients, enhancing their capabilities in clinical research and functional exploration of both healthy and diseased brains.

Sphering Group

Venture Round in 2012
Sphering Group specializes in the design, manufacture, and distribution of advanced chimney and ventilation systems, positioning itself as a key player in the flue and air treatment sector across Europe. The company focuses on creating stable, clean, and sustainable indoor environments for residential, commercial, and industrial clients. With a diverse portfolio of products and solutions, Sphering Group has established a significant presence in various European markets, including Italy, Belgium, France, Germany, Poland, and the Benelux region. The organization operates six industrial production plants and 22 distribution branches, employing over 600 staff. It reported a consolidated turnover of EUR 85 million in 2019. In addition to its manufacturing capabilities, Sphering Group, through its Joncoux brand, offers HVAC specialists a range of network systems and components tailored for large and medium-sized installations, ensuring high quality and innovative solutions in climate control.

Aplix

Venture Round in 2011
Aplix is a global manufacturer specializing in adhesive fastening solutions for various industries. The company caters to market leaders by providing innovative products tailored to specific needs across sectors such as aircraft, automotive, cleaning, hygiene, medical, packaging, building, and other specialized fields. Aplix operates six manufacturing plants located in the U.S., France, Brazil, and China, along with sales offices worldwide. Their offerings include hook and loop fastening systems, ensuring clients receive customized products that are both convenient and cost-effective.

Polyplus-transfection

Venture Round in 2011
Polyplus-transfection SA is a biotechnology company based in Illkirch-Graffenstaden, France, specializing in the development and sale of solutions for nucleic acid delivery across research, bioproduction, and therapeutic applications. Established in 2001 and ISO 9001-certified since 2002, the company offers a diverse range of proprietary reagents for the transfection of genes, oligonucleotides, and siRNA. These products facilitate various applications including enhanced in vivo delivery, molecular biology, diagnostics, gene expression, RNA interference, and protein production. Polyplus-transfection's reagents are increasingly utilized in clinical trials globally, supported by a network of distributors. The company also holds a comprehensive portfolio of patents and licenses, featuring innovative methods for therapeutic siRNA delivery.

EndoControl

Series A in 2010
EndoControl SA is a French company founded in 2006, specializing in the development and distribution of collaborative robots, or "cobots," designed to assist in laparoscopic surgery. The company offers a variety of innovative products aimed at enhancing surgical precision and efficiency. Key offerings include the VIKY EP, a motorized endoscope positioner that can be controlled by voice or foot, the VIKY UP, a motorized uterus positioner that facilitates access to intra-abdominal areas, and JAIMY, an articulated robotized instrument designed for 5-mm incisions. These solutions not only help surgeons navigate the complexities of minimally invasive procedures but also improve patient outcomes by reducing scarring and recovery time. EndoControl operates both in France and internationally, reflecting its commitment to advancing surgical technology. Since June 2019, EndoControl has been a subsidiary of Canady Life Sciences, Inc.

EndoControl

Seed Round in 2007
EndoControl SA is a French company founded in 2006, specializing in the development and distribution of collaborative robots, or "cobots," designed to assist in laparoscopic surgery. The company offers a variety of innovative products aimed at enhancing surgical precision and efficiency. Key offerings include the VIKY EP, a motorized endoscope positioner that can be controlled by voice or foot, the VIKY UP, a motorized uterus positioner that facilitates access to intra-abdominal areas, and JAIMY, an articulated robotized instrument designed for 5-mm incisions. These solutions not only help surgeons navigate the complexities of minimally invasive procedures but also improve patient outcomes by reducing scarring and recovery time. EndoControl operates both in France and internationally, reflecting its commitment to advancing surgical technology. Since June 2019, EndoControl has been a subsidiary of Canady Life Sciences, Inc.

Bel'M

Acquisition in 2005
Bel'M is a manufacturer based in Machecoul, France, specializing in the design and production of entrance doors and windows. The company offers a diverse range of materials, including wood, aluminum, steel, and fiberglass, allowing for various artistic styles and finishes. This capability enables clients to create customized products that meet their specific aesthetic and functional requirements.

Bilcocq

Acquisition in 2004
Bilcocq is a manufacturer and distributor of architectural hardware and building products, specializing in doors, doorsteps, thresholds, and automatic baseboards. The company develops and manufactures components from aluminum, wood, and PVC for carpentry and fitting projects, including custom metalwork to support durable and precise installations.

Wokup

Venture Round in 2002
Wokup is a software company that provides a multi-platform document publishing software solution. The company was founded in 2000 and is headquartered in Paris, France.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.